Support - HkeyBio

Support

You are here: Home » Support

SERVICE

We focus on autoimmune disease sub-fields, providing targeted preclinical research solutions for new drug R&D, covering model construction, efficacy evaluation and IND application support for various autoimmune diseases.

Cutaneous Autoimmune Diseases

Covering atopic dermatitis, psoriasis and other diseases, we provide rodent/NHP model construction, skin pathological tissue analysis, immune cell subset flow detection and other services, supporting efficacy verification and IND filing documentation for cutaneous autoimmune new drugs.
Respiratory Autoimmune Diseases

Covering asthma, pulmonary fibrosis and other diseases, we provide efficacy evaluation services such as airway inflammation assessment and lung function testing. Combined with the clinical relevance of NHP models, we improve drug translation efficiency.
Gastrointestinal Autoimmune Diseases

Focusing on inflammatory bowel disease (ulcerative colitis, Crohn’s disease) and other conditions, we provide intestinal pathological histology analysis, intestinal mucosal immune function detection and other services, adapting to R&D needs of different drug types such as small molecules and biological agents.
Rheumatic Autoimmune Diseases

For rheumatoid arthritis, systemic lupus erythematosus and other diseases, relying on 50+ NHP models to replicate clinical characteristics, we provide in vivo efficacy evaluation and mechanism verification services for multi-target drugs to support R&D decision-making.
Neurological Autoimmune Diseases

For diseases such as multiple sclerosis and myasthenia gravis, we provide dual-system models (rodent + NHP) with supporting services including neuropathological analysis, neurological function scoring, and immune cell infiltration detection, supporting mechanism research and IND filings for neurological autoimmune new drugs.
Endocrine Autoimmune Diseases

Covering diseases such as type 1 diabetes mellitus and autoimmune thyroiditis, we provide disease model construction, endocrine function testing, and autoantibody screening services, adapting to efficacy verification and R&D needs of metabolic autoimmune new drugs.